INDP·45339J204·US·equity·Healthcare - Biotechnology-Activist
INDP (INDAPTUS THERAPEUTICS INC) is held by 3 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($71,013), GEODE CAPITAL MANAGEMENT, LLC ($49,152), MORGAN STANLEY ($4,909). Net institutional sentiment: Mixed.
See how INDP's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer